- Conditions
- Breast Cancer, Cervical Cancer, Colon Rectal Cancer, Endometrial Cancer, Melanoma (Skin Cancer), Ovarian Cancer, Sarcoma, Testicular Cancer, Thyroid Cancer
- Interventions
- Adapted patient navigation program targeting adolescent and young adult cancer survivors
- Behavioral
- Lead sponsor
- Kaiser Permanente
- Other
- Eligibility
- 21 Years to 45 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Pasadena, California
Condition Directory
Ovarian Cancer clinical trials
Directory of U.S. ClinicalTrials.gov public records for Ovarian Cancer. Browse Ovarian Cancer recruiting trials, filter by phase, sponsor, location, or intervention, and open the official ClinicalTrials.gov study record for each result.
By Clinical Trials Finder Guidance last reviewed June 10, 2026 Data synced October 22, 2026 Report an issue
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
375
Shown on this page
12
Current sort
Recently updated
Condition scope
Ovarian Cancer
Additional filters apply within this condition.
The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.
How Ovarian Cancer studies are organized in the registry
Ovarian cancer records are commonly registered as a group — “ovarian, fallopian tube, or primary peritoneal cancer” — so the broader phrasing is normal and not a labeling error. Platinum-sensitivity language (“platinum-resistant,” “platinum-sensitive”) and BRCA status frequently define the study population in titles.
Terms that often appear in related listings
These describe how studies tend to be titled and grouped on ClinicalTrials.gov — they are search vocabulary, not medical guidance.
Showing 229–240 of 375 matching trials for Ovarian Cancer.
Indexed local directory records.
Stored official records
Open in full search- Conditions
- Platinum-resistant Ovarian Cancer
- Interventions
- MEN2501
- Drug
- Lead sponsor
- Stemline Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 7
- States / cities
- Springdale, Arkansas • New Haven, Connecticut • Sarasota, Florida + 4 more
- Conditions
- Breast Cancer, Colon Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer
- Interventions
- EXoPred
- Diagnostic Test
- Lead sponsor
- EXoPERT
- Industry
- Eligibility
- 45 Years and older
- Enrollment
- 1,400 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2026
- U.S. locations
- 9
- States / cities
- Long Beach, California • Los Angeles, California • Honolulu, Hawaii + 6 more
- Conditions
- Platinum-resistant Ovarian Cancer
- Interventions
- Gemcitabine, M-CENK, N-803
- Drug · Biological
- Lead sponsor
- ImmunityBio, Inc.
- Industry
- Eligibility
- 18 Years to 85 Years · Female only
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 2
- States / cities
- El Segundo, California • Newport Beach, California
- Conditions
- Epithelial Ovarian Cancer, Fallopian Tube Cancer, Ovarian Cancer, Ovarian Carcinoma, Primary Peritoneal Carcinoma, Stage II Fallopian Tube Cancer, Stage II Ovarian Cancer, Stage II Ovary Cancer, Stage III Fallopian Tube Cancer, Stage III Ovarian Cancer, Stage III Ovary Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Cancer, Stage IV Ovary Cancer
- Interventions
- Etodolac, Mind-body resilience training, Music therapy, Propranolol
- Drug · Behavioral
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 35 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 7
- States / cities
- Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more
- Conditions
- Ovarian Cancer
- Interventions
- Carboplatin, olaparibp, embro
- Drug
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2030
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Adenoid Cystic Carcinoma, Breast Cancer, Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Triple Negative Breast Cancer
- Interventions
- Emi-Le
- Drug
- Lead sponsor
- Day One Biopharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 360 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 26
- States / cities
- Phoenix, Arizona • Orange, California • San Francisco, California + 20 more
- Conditions
- Anal Cancer, Bile Duct Cancer, Bladder Cancer, Breast Cancer, Central Nervous System Cancer, Central Nervous System Tumor, Colon Cancer, Duodenal Cancer, Endometrial Cancer, Esophageal Cancer, Familial Adenomatous Polyposis, Gallbladder Cancer, Gastric Cancer, Gastrointestinal Stromal Tumors, Healthy Control, Hypopharyngeal Cancer, Kidney Cancer, Laryngeal Cancer, Leukemia, Lip Cancer, Liver Cancer, Lung Cancer, Lynch Syndrome, Melanoma, Mesothelioma, Multiple Myeloma, Nasal Cavity Cancer, Nasopharyngeal Cancer, Neuroendocrine Tumors, Oral Cavity Cancer, Oropharyngeal Cancer, Ovarian Cancer, Pancreatic Cancer, Paranasal Sinus Cancer, Penile Cancer, Peritoneal Surface Malignancies, Plasma Cell Dyscrasia, Prostate Cancer, Rectal Cancer, Salivary Gland Cancer, Sarcoma, Skin Cancer, Small Intestine Cancer, Testicular Cancer, Thymus Cancer, Thyroid Cancer, Unknown Primary Tumor, Ureter Cancer, Urethral Cancer, Vaginal Cancer
- Interventions
- Not listed
- Lead sponsor
- University of Nebraska
- Other
- Eligibility
- 19 Years to 110 Years
- Enrollment
- 999,999 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2099
- U.S. locations
- 42
- States / cities
- Greenwood Village, Colorado • Manchester, Connecticut • Daytona Beach, Florida + 34 more
- Conditions
- Appendiceal Cancer, Appendiceal Neoplasms, Breast Cancer, Cholangiocarcinoma, Colorectal Cancer, Colorectal Neoplasms, Gynecologic Cancer, Gynecologic Neoplasms, Ovarian Cancer, Ovarian Neoplasms, Peritoneal Carcinomatosis, Peritoneal Neoplasms
- Interventions
- CT Scan CAP, ECG, Laparoscopy, Nilotinib, Paclitaxel, Peritoneal biopsies + ascites washings
- Diagnostic Test · Procedure · Drug
- Lead sponsor
- National Cancer Institute (NCI)
- NIH
- Eligibility
- 18 Years and older
- Enrollment
- 21 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2025
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Cholangiocarcinoma Recurrent, Mesothelioma, Malignant, Ovarian Cancer
- Interventions
- SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR
- Biological
- Lead sponsor
- Verismo Therapeutics
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 42 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 5
- States / cities
- Tampa, Florida • Westwood, Kansas • Philadelphia, Pennsylvania + 2 more
- Conditions
- Gastric/Esophageal Cancer, Head and Neck Squamous Cell Carcinoma, High-Grade Serous Ovarian Cancer, Micro Satellite Stable Colorectal Cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer, Triple Negative Breast Cancer
- Interventions
- Azirkitug, Bevacizumab, Budigalimab, Telisotuzumab Adizutecan
- Drug
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 694 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2027
- U.S. locations
- 20
- States / cities
- Duarte, California • Irvine, California • Los Angeles, California + 15 more
- Conditions
- Castration-resistant Prostate Cancer, Colorectal Cancer, Endometrium Cancer, Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma, High Grade Serous Ovarian Cancer, Non Small Cell Lung Cancer, Triple Negative Breast Cancer
- Interventions
- IDE034
- Drug
- Lead sponsor
- IDEAYA Biosciences
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 15
- States / cities
- Denver, Colorado • Sarasota, Florida • Detroit, Michigan + 10 more
About this Ovarian Cancer clinical trials directory page
- What this page lists
- U.S. ClinicalTrials.gov public records that list Ovarian Cancer as a study condition, including recruiting, not yet recruiting, and active not recruiting trials across phase 1, phase 2, and phase 3.
- How to narrow results
- Use the filters above to scope by intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, age, or NCT ID within Ovarian Cancer.
- Where the data comes from
- Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, ranking of trials by quality, or AI-generated medical summaries.
Related: all condition pages, browse by drug or therapy, browse by U.S. city, browse by sponsor, or open the full search for Ovarian Cancer.